Guska
PrivateLast Round
Seed
Feb 28, 2024
Total Funding Raised
$750,000
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Guska is a biotechnology company developing oncolytic virus-based cancer therapies using AI and synthetic biology to engineer RNA viruses that selectively destroy tumor cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guska Comparables
Compare Guska with similar companies based on industry and business-model similarity.
Guska Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 28, 2024 |
Guska Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ficus Capital | Seed |
| LAB+ Company Builder | Seed |
| Institut Pasteur de Montevideo | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 229% MoM, reaching 1.5K.
- Jul 26, 2026
Monthly visitors increased 1129% MoM, from 38 to 467.
Guska Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Guska's valuation, stock price, and market status.
Is Guska a public or private company?
Guska is a private company.
What is the current stock price of Guska?
Guska is a private company with no public stock price. No recent secondary market data is available.
How much is Guska worth (valuation)?
Valuation information for Guska is not publicly available.
Can I buy Guska stock?
Guska shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Guska's last funding round?
Guska's most recent funding round was Seed on February 28, 2024.
Who are the main investors in Guska?
Key investors in Guska include LAB+ Company Builder.
Will Guska IPO soon?
No public IPO plans have been announced for Guska.
How can I track Guska secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Guska's secondary market activity and sign up for updates.